Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-10-20

FDA Approved: BUMETANIDE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for bumetanide from Sandoz Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUMETANIDE (bumetanide)

Snippet

SUPPL AP for BUMETANIDE (BUMETANIDE)